IRS1 and breast cancer: Further in vitro studies in BC cells have suggested that miR-152 can attenuate the expression of HIF-1α and VEGF as well as the phosphorylation of AKT and extracellular signal-regulated kinases (ERK) through direct targeting of IGF-IR and insulin receptor substrate 1 (IRS1) transcripts [90].